Fresenius To Pay $50M For Impeding FDA Investigation
Indian drug manufacturer Fresenius Kabi Oncology Ltd. will plead guilty and pay $50 million to end claims that it destroyed and hid records related to the production of cancer drugs before...To view the full article, register now.
Already a subscriber? Click here to view full article